Pharmaceutical Manufacturing Market Size, Share, Growth Analysis, By Drug(Prescription drugs, over-the-counter medications, and biologics), By Manufacturing process(Active pharmaceutical ingredient (API) manufacturing, finished dosage form (FDF) manufacturing, and packaging), By Therapeutic area(Cardiovascular, oncology, central nervous system, respiratory), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2270 | Region: Global | Published Date: February, 2024
Pages: 157 |Tables: 92 |Figures: 76

Pharmaceutical Manufacturing Market Insights

Pharmaceutical Manufacturing Market size was valued at USD 425.9 billion in 2021 and is poised to grow from USD 572.10 billion in 2023 to USD 1607.16 billion by 2030, at a CAGR of 15.9% during the forecast period (2023-2030).

The global pharmaceutical manufacturing market continues to thrive as an essential sector in the healthcare industry. With a focus on research, development, and production of medications, the market is driven by factors such as rising population, increasing prevalence of chronic diseases, and advancements in medical technology.

The demand for innovative drugs, personalized medicine, and biologics further propels market growth. Moreover, expanding healthcare infrastructure, government initiatives to improve access to healthcare, and growing investments in pharmaceutical manufacturing facilities contribute to the market's expansion. However, challenges such as stringent regulations, pricing pressures, and intellectual property rights issues pose potential obstacles to the market's overall progress.

US Pharmaceutical Manufacturing Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 425.9 billion

Largest Segment

Tablets

Fastest Growth

Tablets

Growth Rate

15.9% CAGR

Global Pharmaceutical Manufacturing by region
Country Share for North America (%)

To get more reports on the above market click here to Buy The Report

Pharmaceutical Manufacturing Market Segmental Analysis

The global pharmaceutical manufacturing industry can be segmented into various categories based on factors such as drug type, manufacturing process, therapeutic area, and geography. In terms of drug type, the industry encompasses the production of prescription drugs, over-the-counter medications, and biologics. The manufacturing process can be divided into active pharmaceutical ingredient (API) manufacturing, finished dosage form (FDF) manufacturing, and packaging. Therapeutic areas covered by the industry include cardiovascular, oncology, central nervous system, respiratory, and infectious diseases. Geographically, the global pharmaceutical manufacturing sector is spread across major regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Pharmaceutical Manufacturing Market Analysis By Drug

Prescription drugs will lead the global pharmaceutical manufacturing market as these drugs are often used for the treatment of chronic diseases, acute conditions, or specialized therapies. Prescription drugs are subject to stringent regulations to ensure their safety, efficacy, and appropriate usage.

Over-the-counter medications segment will also grow during the forecast period as these drugs are typically used for the treatment of common ailments such as cold and flu symptoms, pain relief, allergies, and indigestion. OTC drugs undergo regulatory scrutiny to ensure their safety and appropriate usage.

Global Pharmaceutical Manufacturing by Formulation

To get detailed analysis on other segments, Request For Free Sample Report

Pharmaceutical Manufacturing Market Regional Insights

The global pharmaceutical manufacturing industry exhibits diverse regional characteristics. North America, led by the United States, dominates the market due to its advanced infrastructure, well-established regulatory frameworks, and significant investments in research and development. Europe, particularly countries like Germany, Switzerland, and the United Kingdom, is known for its strong pharmaceutical manufacturing capabilities and adherence to quality standards. Asia Pacific, led by China and India, is a major hub for generic drug production and contract manufacturing, benefiting from cost advantages and a large pool of skilled labor. Additionally, emerging markets in Latin America and Africa are witnessing growth due to increasing healthcare access and favorable government policies attracting pharmaceutical investments.

Global Pharmaceutical Manufacturing by geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Pharmaceutical Manufacturing Market Dynamics

Pharmaceutical Manufacturing Market Drivers

Increased Investment in Developing Healthcare Infrastructure to Bolster Market Growth

  • One driver in the global pharmaceutical manufacturing market is the increasing demand for healthcare products and medications worldwide. The growing global population, along with the rising prevalence of chronic diseases and infectious illnesses, has led to a surge in the need for pharmaceuticals. Additionally, advancements in medical technology and an aging population have also contributed to the rising demand for innovative drugs and therapies. This drives pharmaceutical manufacturers to expand their production capabilities, invest in research and development, and adopt new manufacturing technologies to meet the growing market demand.

Pharmaceutical Manufacturing Market Restraints

Stringent Regulations

  • One major restraint in the pharmaceutical manufacturing market is the stringent regulatory environment. Governments and regulatory bodies impose strict regulations and standards to ensure the safety, efficacy, and quality of pharmaceutical products. Compliance with these regulations requires significant investments in infrastructure, quality control systems, and documentation. Non-compliance can result in heavy penalties and damage to a company's reputation. Moreover, the complex and time-consuming regulatory approval process for new drugs can hinder the speed of product launches, delaying the availability of life-saving medications to patients. These regulatory challenges pose barriers to entry for new players and increase the overall cost and time involved in pharmaceutical manufacturing.

Request Free Customization of this report to help us to meet your business objectives.

Pharmaceutical Manufacturing Market Competitive Landscape

The global pharmaceutical manufacturing sector is characterized by a highly competitive landscape, driven by numerous factors including technological advancements, stringent regulations, patent expirations, and the increasing demand for innovative healthcare solutions. These industry giants boast extensive research and development capabilities, strong distribution networks, and a diverse portfolio of products across various therapeutic areas. However, the industry also features a significant presence of generic pharmaceutical manufacturers, particularly from emerging markets like India and China. These companies leverage cost advantages and large-scale production capabilities to offer affordable alternatives to branded drugs. Additionally, contract manufacturing organizations (CMOs) play a vital role in the sector, providing specialized manufacturing services to pharmaceutical companies. The intense competition in this dynamic landscape fosters innovation, encourages strategic partnerships, and drives continuous improvements in manufacturing processes, ultimately benefiting patients worldwide with a wide range of high-quality pharmaceutical products.

Pharmaceutical Manufacturing Market Top Player’s Company Profiles

  • Johnson & Johnson (United States)
  • Merck & Co., Inc. (United States)
  • GlaxoSmithKline plc (United Kingdom)
  • Sanofi (France)
  • AstraZeneca (United Kingdom)
  • AbbVie Inc. (United States)
  • Bristol-Myers Squibb Company (United States)
  • Eli Lilly and Company (United States)
  • Gilead Sciences, Inc. (United States)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Novo Nordisk A/S (Denmark)
  • Amgen Inc. (United States)
  • Bayer AG (Germany)
  • Astellas Pharma Inc. (Japan)
  • Boehringer Ingelheim GmbH (Germany)
  • Daiichi Sankyo Company, Limited (Japan)
  • Teva Pharmaceutical Industries Ltd. (Israel)

Pharmaceutical Manufacturing Market Recent Developments

  • In February 2021, WuXi STA, a subsidiary of WuXiAppTec, announced the purchase of a Switzerland-based manufacturing facility from Bristol Myers Squibb. Thus, in-house manufacturing is expected to witness significant growth in the coming years.
  • In July 2021, the United States Pharmacopeia (USP), an independent, scientific nonprofit organization, reported the acquisition of Pharmatech Associates, Inc. With the addition of Pharmatech Associates' expertise, USP further advanced its 200-year mission to help ensure access to quality medicines by extending services that assist manufacturers in meeting global quality standards across the drug and product lifecycle.

Pharmaceutical Manufacturing Key Market Trends

  • One of the key market trends in global pharmaceutical manufacturing is the increasing demand for personalized medicine and targeted therapies. Advancements in technology and genomics have paved the way for more precise and individualized treatments, leading to a shift in pharmaceutical manufacturing towards smaller batches and flexible production processes. Additionally, there is a growing emphasis on the development of biologics and biosimilars, driven by the rise in chronic diseases and the need for innovative therapies. Moreover, sustainability and eco-friendly practices have gained importance, with pharmaceutical manufacturers focusing on reducing waste, improving energy efficiency, and adopting green manufacturing processes to meet environmental regulations and consumer expectations.

Pharmaceutical Manufacturing Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types of team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

According to our analysis the Global Oxidative Stress Assay Market is poised for significant growth and holds promising future prospects. Oxidative stress, caused by an imbalance between reactive oxygen species (ROS) production and the body's antioxidant defense system, is implicated in various diseases and disorders. The increasing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurodegenerative disorders, is driving the demand for oxidative stress assays. Additionally, the growing awareness about preventive healthcare and the importance of early disease detection further contribute to market expansion. Advancements in technology, including the development of high-throughput screening methods and improved assay kits, enhance the accuracy, sensitivity, and efficiency of oxidative stress testing. Moreover, the integration of oxidative stress assays in drug discovery and research activities foster's market growth.

Report Metric Details
Market size value in 2023 USD 425.9 billion
Market size value in 2031 USD 1607.16 billion
Growth Rate 15.9%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Drug
    • Prescription drugs, over-the-counter medications, and biologics
  • Manufacturing process
    • Active pharmaceutical ingredient (API) manufacturing, finished dosage form (FDF) manufacturing, and packaging
  • Therapeutic area
    • Cardiovascular, oncology, central nervous system, respiratory, and infectious diseases
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Johnson & Johnson (United States)
  • Merck & Co., Inc. (United States)
  • GlaxoSmithKline plc (United Kingdom)
  • Sanofi (France)
  • AstraZeneca (United Kingdom)
  • AbbVie Inc. (United States)
  • Bristol-Myers Squibb Company (United States)
  • Eli Lilly and Company (United States)
  • Gilead Sciences, Inc. (United States)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Novo Nordisk A/S (Denmark)
  • Amgen Inc. (United States)
  • Bayer AG (Germany)
  • Astellas Pharma Inc. (Japan)
  • Boehringer Ingelheim GmbH (Germany)
  • Daiichi Sankyo Company, Limited (Japan)
  • Teva Pharmaceutical Industries Ltd. (Israel)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Pharmaceutical Manufacturing Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Pharmaceutical Manufacturing Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Pharmaceutical Manufacturing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Pharmaceutical Manufacturing Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Pharmaceutical Manufacturing Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Pharmaceutical Manufacturing Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Pharmaceutical Manufacturing Market size was valued at USD 425.9 billion in 2021 and is poised to grow from USD 572.10 billion in 2023 to USD 1607.16 billion by 2030, at a CAGR of 15.9% during the forecast period (2023-2030).

The pharmaceutical manufacturing sector is characterized by a highly competitive landscape, driven by numerous factors including technological advancements, stringent regulations, patent expirations, and the increasing demand for innovative healthcare solutions. These industry giants boast extensive research and development capabilities, strong distribution networks, and a diverse portfolio of products across various therapeutic areas. However, the industry also features a significant presence of generic pharmaceutical manufacturers, particularly from emerging markets like India and China. These companies leverage cost advantages and large-scale production capabilities to offer affordable alternatives to branded drugs. Additionally, contract manufacturing organizations (CMOs) play a vital role in the sector, providing specialized manufacturing services to pharmaceutical companies. The intense competition in this dynamic landscape fosters innovation, encourages strategic partnerships, and drives continuous improvements in manufacturing processes, ultimately benefiting patients worldwide with a wide range of high-quality pharmaceutical products. 'Johnson & Johnson (United States)', 'Pfizer Inc. (United States)', 'Novartis International AG (Switzerland)', 'Roche Holding AG (Switzerland)', 'Merck & Co., Inc. (United States)', 'GlaxoSmithKline plc (United Kingdom)', 'Sanofi (France)', 'AstraZeneca (United Kingdom)', 'AbbVie Inc. (United States)', 'Bristol-Myers Squibb Company (United States)', 'Eli Lilly and Company (United States)', 'Gilead Sciences, Inc. (United States)', 'Takeda Pharmaceutical Company Limited (Japan)', 'Novo Nordisk A/S (Denmark)', 'Amgen Inc. (United States)', 'Bayer AG (Germany)', 'Astellas Pharma Inc. (Japan)', 'Boehringer Ingelheim GmbH (Germany)', 'Daiichi Sankyo Company, Limited (Japan)', 'Teva Pharmaceutical Industries Ltd. (Israel)'

One driver in the pharmaceutical manufacturing market is the increasing demand for healthcare products and medications worldwide. The growing population, along with the rising prevalence of chronic diseases and infectious illnesses, has led to a surge in the need for pharmaceuticals. Additionally, advancements in medical technology and an aging population have also contributed to the rising demand for innovative drugs and therapies. This drives pharmaceutical manufacturers to expand their production capabilities, invest in research and development, and adopt new manufacturing technologies to meet the growing market demand.

One of the key market trends in pharmaceutical manufacturing is the increasing demand for personalized medicine and targeted therapies. Advancements in technology and genomics have paved the way for more precise and individualized treatments, leading to a shift in pharmaceutical manufacturing towards smaller batches and flexible production processes. Additionally, there is a growing emphasis on the development of biologics and biosimilars, driven by the rise in chronic diseases and the need for innovative therapies. Moreover, sustainability and eco-friendly practices have gained importance, with pharmaceutical manufacturers focusing on reducing waste, improving energy efficiency, and adopting green manufacturing processes to meet environmental regulations and consumer expectations.

The pharmaceutical manufacturing industry exhibits diverse regional characteristics. North America, led by the United States, dominates the market due to its advanced infrastructure, well-established regulatory frameworks, and significant investments in research and development. Europe, particularly countries like Germany, Switzerland, and the United Kingdom, is known for its strong pharmaceutical manufacturing capabilities and adherence to quality standards. Asia Pacific, led by China and India, is a major hub for generic drug production and contract manufacturing, benefiting from cost advantages and a large pool of skilled labor. Additionally, emerging markets in Latin America and Africa are witnessing growth due to increasing healthcare access and favorable government policies attracting pharmaceutical investments.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQMIG35I2270

$5,300
BUY NOW GET FREE SAMPLE